FDA NDC Directory · JSON-LD · Markdown

IMAAVY

NDC 57894-800 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namenipocalimab
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761430
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsNIPOCALIMAB (185 mg/mL)
Marketing started20250429
Package count1

External sources

Source: openFDA. Public-domain (CC0).